BCM
AVNS

Bridgeway Capital Management’s Avanos Medical AVNS Stock Holding History

Bridgeway Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.81M Sell
272,186
-39,293
-13% -$529K 0.08% 319
2025
Q4 		$3.5M Buy
311,479
+20,807
+7% +$238K 0.07% 336
2025
Q3 		$3.36M Buy
290,672
+67
+0% +$785 0.07% 367
2025
Q2 		$3.56M Buy
290,605
+9,006
+3% +$113K 0.08% 329
2025
Q1 		$4.04M Buy
281,599
+8,348
+3% +$130K 0.1% 286
2024
Q4 		$4.35M Buy
273,251
+127,591
+88% +$2.53M 0.1% 302
2024
Q3 		$3.5M Sell
145,660
-188,991
-56% -$4.32M 0.08% 367
2024
Q2 		$6.67M Sell
334,651
-1,320
-0.4% -$25.7K 0.16% 188
2024
Q1 		$6.69M Buy
335,971
+13,409
+4% +$259K 0.14% 230
2023
Q4 		$7.24M Buy
322,562
+14,784
+5% +$305K 0.16% 201
2023
Q3 		$6.22M Buy
307,778
+12,166
+4% +$276K 0.15% 215
2023
Q2 		$7.56M Buy
295,612
+4,774
+2% +$126K 0.18% 171
2023
Q1 		$8.65M Buy
290,838
+6,921
+2% +$201K 0.23% 116
2022
Q4 		$7.68M Buy
+283,917
New +$6.94M 0.2% 151
2017
Q3 		– Sell
-44,800
Closed -$1.76M – 1396
2017
Q2 		$1.76M Hold
44,800
– – 0.02% 622
2017
Q1 		$1.71M Hold
44,800
– – 0.02% 625
2016
Q4 		$1.66M Hold
44,800
– – 0.02% 638
2016
Q3 		$1.55M Hold
44,800
– – 0.02% 623
2016
Q2 		$1.46M Hold
44,800
– – 0.02% 639
2016
Q1 		$1.29M Buy
44,800
+37,800
+540% +$1.01M 0.02% 658
2015
Q4 		$234K Buy
+7,000
New +$218K ﹤0.01% 1262

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Bridgeway Capital Management's AVNS Position: Q1 2026 in Review

Bridgeway Capital Management reduced its Avanos Medical (AVNS) stake by 13% in Q1 2026, selling an estimated $529K and leaving 272,186 shares worth $3.81M. The position accounts for 0.08% of the portfolio, ranked #319.

Bridgeway Capital Management first reported a position in AVNS in Q4 2015 and has held it in 21 quarters since. The position peaked at $8.65M in Q1 2023. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Bridgeway Capital Management held 272,186 shares of Avanos Medical worth $3.81M as of Q1 2026.
  • Bridgeway Capital Management sold 39,293 Avanos Medical shares in Q1 2026, an estimated $529K.
  • Avanos Medical made up 0.08% of Bridgeway Capital Management's portfolio in Q1 2026, its #319 holding.
  • Bridgeway Capital Management first reported a position in Avanos Medical in Q4 2015 and has held it in 21 quarters since.
  • Bridgeway Capital Management's Avanos Medical position peaked at $8.65M in Q1 2023.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.